Can You Take Ibuprofen with Zolpidem?

Severity assessment

Informational. No direct, significant drug-drug interaction has been identified between ibuprofen and zolpidem in available regulatory information or common drug interaction databases.

Mechanism (plain English)

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by reducing the production of prostaglandins, substances in the body that cause pain, fever, and inflammation. It primarily acts by inhibiting cyclooxygenase (COX) enzymes [1]. Ibuprofen is metabolized in the liver and excreted by the kidneys [1].

Zolpidem is a sedative-hypnotic medication used for the short-term treatment of insomnia. It works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter in the brain that calms nerve activity. Specifically, zolpidem selectively binds to the omega-1 receptors on the GABA-A receptor complex, leading to its sedative effects [2, 3]. Zolpidem is primarily metabolized by the liver, mainly through the CYP3A4 enzyme [3].

Given their distinct mechanisms of action and metabolic pathways, ibuprofen and zolpidem are not expected to have a direct pharmacokinetic or pharmacodynamic interaction that would significantly alter their effects or increase adverse events when taken together. Ibuprofen does not typically cause central nervous system (CNS) depression, which is the primary concern with zolpidem interactions.

Evidence level

Theoretical. While no direct regulator-flagged or guideline-supported interaction for this specific pair has been found, the assessment is based on the known pharmacological profiles of each drug and general principles of drug interactions [1, 2, 3].

Top regulator advisories (cite verbatim or close paraphrase)

• TGA (Australia): No pair-specific public advisory found. Applicable product information for ibuprofen indicates it is an NSAID with analgesic, antipyretic, and anti-inflammatory properties [4]. For zolpidem, the TGA has previously imposed a boxed warning in product information documents regarding next-day impairment [5].
• MHRA / NICE (UK): No specific interaction between ibuprofen and zolpidem is listed in the MHRA Summary of Product Characteristics (SPC) for zolpidem [3]. The BNF (British National Formulary) generally states that many interactions are harmless, and even potentially harmful ones can often be managed [6].
• FDA / CDC (US): No specific interaction between ibuprofen and zolpidem is listed in the FDA labels for ibuprofen [1] or zolpidem [2]. The FDA has issued communications regarding the risk of next-morning impairment with zolpidem [7].
• EMA (Europe): No specific interaction between ibuprofen and zolpidem is detailed in the available EMA guidance or product information for zolpidem [3].

Clinical risk factors that elevate the danger

While a direct interaction between ibuprofen and zolpidem is not established, certain factors can increase the risk of adverse effects when either drug is used:

For Zolpidem:

• Concomitant use of other CNS depressants (e.g., alcohol, opioids, benzodiazepines, certain antidepressants): Increases the risk of additive CNS depressant effects, leading to excessive drowsiness, impaired coordination, respiratory depression, and complex sleep behaviors [2, 3].
• Hepatic impairment: Zolpidem clearance is reduced in patients with liver problems, increasing drug levels and the risk of adverse effects [2, 3].
• Elderly patients: May be more sensitive to zolpidem's effects, increasing the risk of falls and next-day impairment [2, 3].
• History of substance misuse or psychiatric disorders: Increases the risk of dependence and abuse with zolpidem [3].

For Ibuprofen:

• History of gastrointestinal ulcers or bleeding: Increases the risk of serious GI bleeding [1].
• Concomitant use of anticoagulants or corticosteroids: Increases the risk of GI bleeding [1].
• Cardiovascular disease, high blood pressure, heart failure: NSAIDs like ibuprofen can increase the risk of serious cardiovascular thrombotic events, including heart attack and stroke [1].
• Renal impairment: Ibuprofen can worsen kidney function [1].
• Age 60 or older: Increased risk of stomach bleeding and cardiovascular events [1].

What a patient should be told

• Risk is generally low: There is no known significant interaction between ibuprofen and zolpidem. You can generally take them together if prescribed or recommended by your doctor or pharmacist.
• Watch for unusual symptoms: Even though no direct interaction is expected, pay attention to how you feel. If you experience unusual drowsiness, dizziness, confusion, or any other concerning symptoms, contact your healthcare provider.
• Do not stop zolpidem suddenly: If you are taking zolpidem regularly, do not stop it abruptly without talking to your doctor, as this can lead to withdrawal symptoms or rebound insomnia.
• Discuss alternatives: If you have concerns about taking these medications together, or if you experience any side effects, talk to your doctor or pharmacist about safer alternatives or adjustments to your treatment plan.
• Urgent care triggers: Seek immediate medical attention if you experience severe dizziness, extreme sleepiness, difficulty breathing, chest pain, signs of internal bleeding (e.g., black, tarry stools, vomiting blood), or any other severe or unexpected reactions.

Top 3 sources (with full citation)

1. Advil (Ibuprofen) Label. U.S. Food and Drug Administration. Revised December 14, 2021. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018989Orig1s099lbl.pdf
2. Zolpidem Tartrate Capsules Prescribing Information. U.S. Food and Drug Administration. Revised May 2023. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215721s000lbl.pdf
3. Zolpidem 10 mg Film-Coated Tablets Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency (MHRA). Revised March 5, 2026. Available at: https://mhraproducts4853.blob.core.windows.net/docs/116073fa04c35c9987f7a0ceaa5a23cbff718813

Notes for the reviewing pharmacist

Currently, there is no evidence from major regulatory bodies (FDA, MHRA, TGA, EMA) or prominent drug interaction checkers (e.g., Drugs.com, GoodRx) to suggest a direct, clinically significant interaction between ibuprofen and zolpidem. The primary concern with zolpidem is its CNS depressant effects, which can be exacerbated by other CNS depressants like alcohol, opioids, and certain anxiolytics or antidepressants. Ibuprofen, as an NSAID, does not typically exert CNS depressant effects. Therefore, a pharmacodynamic interaction leading to increased sedation or respiratory depression is not anticipated. Pharmacokinetic interactions are also unlikely given their distinct metabolic pathways (ibuprofen primarily via CYP2C9 and CYP2C8, zolpidem primarily via CYP3A4, with minor contributions from CYP1A2, CYP2C9, CYP2D6, and CYP2C19). While zolpidem does have some metabolism via CYP2C9, ibuprofen is not a strong inhibitor or inducer of CYP3A4, and zolpidem is not a strong inhibitor or inducer of CYP2C9, making a significant pharmacokinetic interaction improbable. Pharmacists should counsel patients on the individual side effects of each medication and general medication safety, particularly regarding zolpidem's potential for next-day impairment and complex sleep behaviors, and ibuprofen's gastrointestinal and cardiovascular risks. Patients should be advised to report any unusual or severe symptoms. The absence of a flagged interaction does not preclude the possibility of idiosyncratic reactions or interactions in patients with multiple comorbidities or polypharmacy, necessitating a comprehensive patient assessment.

Source metadata JSON

{
  "pair": "ibuprofen + zolpidem",
  "severity": "Informational",
  "evidence_level": "Theoretical",
  "source_urls": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018989Orig1s099lbl.pdf;https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215721s000lbl.pdf;https://mhraproducts4853.blob.core.windows.net/docs/116073fa04c35c9987f7a0ceaa5a23cbff718813;https://www.tga.gov.au/sites/default/files/otc-medicine-monograph-ibuprofen-oral-use.pdf;https://www.tga.gov.au/safety/recalls-and-other-market-actions/market-actions/zolpidem-stilnox;https://bnf.nice.org.uk/interactions/appendix-1-interactions/;https://www.fda.gov/files/drugs/published/Drug-Safety-Communication--Risk-of-next-morning-impairment-after-use-of-insomnia-drugs--FDA-requires-lower-recommended-doses-for-certain-drugs-containing-zolpidem-%28Ambien--Ambien-CR--Edluar--and-Zolpimist%29.pdf"
}